Circulating Tumor Cells Market Expands as Liquid Biopsy Integration Strengthens Clinical Oncology Pathways
The circulating tumor cells (CTC) market has demonstrated robust expansion, underpinned by accelerating adoption of liquid biopsy technologies and rising global cancer incidence. According to publicly available data from authoritative sources, the circulating tumor cells market size was valued at USD 12.28 billion in 2024, growing at a CAGR of 13.3% during 2025–2034. This sustained...
0 Commentaires 0 Parts 8 Vue 0 Aperçu